Profil bibliographique

Flora Zagouri

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

70Publications signalées

332Citations signalées

2Affiliations récentes

Institutions déclarées

Alexandra Hospital Hellenic Cooperative Oncology Group

Domaines associés

Ovarian cancer diagnosis and treatmentBreast Cancer Treatment StudiesEndometrial and Cervical Cancer TreatmentsCancer Immunotherapy and BiomarkersPARP inhibition in cancer therapy

Publications récentes

2026 conference-abstractOpenAlex

Avelumab (Ave) in combination with other anticancer agents as first-line maintenance (1LM) treatment for advanced urothelial carcinoma (aUC): Primary analysis from the JAVELIN Bladder Medley phase 2 trial.

Jeannie Hoffman-Censits, Marinos Tsiatas, Peter Mu-Hsin Chang, M. Kim et autres

0 citationsJournal of Clinical Oncology

2026 conference-abstractOpenAlex

Abstract PS4-01-20: Clinico-pathological and genomic features of HER2-low early Breast Cancer (eBC). Results of retrospective analysis of seven adjuvant trials by the Hellenic Cooperative Oncology Group (HeCOG)

Sotirios Lakis, Eleftheria Tsolaki, N. Korfiatis, A. Goussia et autres

0 citationsClinical Cancer Research

2026 conference-abstractOpenAlex

Abstract PS4-02-18: Detection of germline and somatic pathogenic variants in patients with de novo metastatic breast cancer (dnMBC) and assessment of their prognostic relevance: A Hellenic Cooperative Oncology Group (HeCOG) translational cohort study

Elena Fountzilas, Kyriaki Papadopoulou, N. Korfiatis, A. Goussia et autres

0 citationsClinical Cancer Research

2025 reviewOpenAlex

Antipsychotic therapy and breast cancer risk: a comprehensive systematic review and meta-analysis

Maria-Triantafyllia Revelou, Charalampos Filippatos, Panagiotis Malandrakis, Evangelos Terpos et autres

0 citationsBreast Cancer

2025 articleOpenAlex

PEMBROLIZUMAB PLUS ADJUVANT CHEMOTHERAPY WITH OR WITHOUT RADIOTHERAPY FOR NEWLY DIAGNOSED HIGH-RISK ENDOMETRIAL CANCER: HEALTH-RELATED QUALITY OF LIFE (HRQOL) FROM THE PHASE 3 ENGOT-EN11/GOG-3053/KEYNOTE-B21 STUDY

Ghanim Khatib, Toon Van Gorp, Weiguo Lv, Emily K. Hill et autres

0 citationsInternational Journal of Gynecological Cancer

Accès ouvert 2025 articleOpenAlex

Rucaparib maintenance for newly diagnosed advanced ovarian cancer: interim overall survival, progression-free survival, and safety at 5 years of follow-up from the phase III ATHENA-MONO/GOG-3020/ENGOT-ov45 study

Rebecca Kristeleit, S. Ghamande, Alla Lisyanskaya, A. Oaknin et autres

6 citationsAnnals of Oncology

2025 articleOpenAlex

Exerkine Responses To An Acute Bout Of Exercise In Breast Cancer Patients Under Chemotherapy

Αrgyro Papadopetraki, Antonios Giannopoulos, Tatiana Giaskevits, Flora Zagouri et autres

0 citationsMedicine & Science in Sports & Exercise

Accès ouvert 2025 articleOpenAlex

A rare splenic and pancreatic inflammatory myofibroblastic tumour with left‑sided portal hypertension and gastric varices: A case report

Eleni Zografos, Alkistis Papatheodoridi, Μαρία Καπαρέλου, Ioanna Tatouli et autres

0 citationsExperimental and Therapeutic Medicine

Accès ouvert 2025 articleOpenAlex

A randomized, phase III study of sacituzumab govitecan versus treatment of the physician’s choice in patients with endometrial cancer after platinum-based chemotherapy and immunotherapy: the ASCENT-GYN-01 study (GOG-3104/ENGOT-en26/APGOT-EN2)

Ramez N. Eskander, Bradley R. Corr, David Cibula, David S.P. Tan et autres

3 citationsInternational Journal of Gynecological Cancer

2025 articleOpenAlex

Durvalumab plus carboplatin/paclitaxel followed by durvalumab with/without olaparib in endometrial cancer: Biomarkers, histological heterogeneity, baseline circulating tumor DNA and efficacy in the DUO-E mismatch repair proficient subpopulation

Kathleen N. Moore, Shannon N. Westin, Hye Sook Chon, Jessica Thomes Pepin et autres

4 citationsGynecologic Oncology

2025 articleOpenAlex

1102P Contribution of bevacizumab (bev) use to safety outcomes in FIRST/ENGOT-OV44

A. Santillan-Gomez, Laure Favier, François Montestruc, Michael Teneriello et autres

0 citationsAnnals of Oncology

2025 articleOpenAlex

1073P 5-year progression-free survival (PFS) with rucaparib (RUCA) maintenance in patients with newly diagnosed advanced ovarian cancer in ATHENA-MONO (GOG-3020/ENGOT-ov45)

Rebecca Kristeleit, Sharad Ghamande, A.S. Lisyanskaya, A. Oaknin et autres

0 citationsAnnals of Oncology

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.